节点文献

琥珀酸美托洛尔缓释片在健康中国人体空腹和高脂餐后单次给药的药代动力学研究

Single-dose pharmacokinetics of metoprolol succinate sustained-release tablets administration during fasting and after high-fat meal in healthy Chinese volunteers

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 王璐吴玥赵玉清周素凤谢利君陈娟董颖张宏文刘云邵凤

【Author】 WANG Lu;WU Yue;ZHAO Yu-qing;ZHOU Su-feng;XIE Li-jun;CHEN Juan;DONG Ying;ZHANG Hong-wen;LIU Yun;SHAO Feng;Phase Ⅰ Clinical Trial Unit,the First Affiliated Hospital of Nanjing Medical University;

【通讯作者】 邵凤;

【机构】 南京医科大学第一附属医院Ⅰ期临床试验研究室

【摘要】 目的评价单次口服琥珀酸美托洛尔缓释片在中国健康受试者体内的药代动力学特征和安全性。方法 7例中国健康志愿者空腹单次口服琥珀酸美托洛尔缓释片47. 5 mg,8例中国健康志愿者在高脂餐后单次口服琥珀酸美托洛尔缓释片47. 5 mg,用液相色谱-串联质谱联用法测定给药后不同时间美托洛尔的血药浓度,并用Win Nonlin 6. 4软件计算主要药代动力学参数。结果本研究未观察到药物相关的不良事件和严重不良事件。空腹单次口服琥珀酸美托洛尔缓释片后的药代动力学参数如下:Cmax为(14. 63±8. 93) ng·m L-1,tmax为(9. 43±2. 76) h,t1/2为(9. 36±5. 76) h,AUC0-t为(343. 63±262. 07) ng·m L-1·h,AUCinf为(359. 65±259. 29) ng·m L-1·h,清除率为(188. 58±109. 10) L·h-1,表观分布容积为(3031. 36±4029. 78) L。高脂餐后单次口服琥珀酸美托洛尔缓释片后的药代动力学参数如下:Cmax为(19. 56±14. 89) ng·m L-1,tmax(6. 00±1. 07) h,t1/2为(6. 27±1. 37) h,AUC0-t为(391. 07±307. 06) ng·m L-1·h,AUCinf为(395. 84±311. 42) ng·m L-1·h,清除率为(225. 97±201. 53) L·h-1,表观分布容积为(2022. 20±1842. 51) L。结论高脂餐后给予琥珀酸美托洛尔缓释片,tmax较空腹给药提前,暴露量未见明显差异。

【Abstract】 Objective To evaluate the pharmacokinetics and safety of single dose of metoprolol succiniate sustained-released tablets under fasting and fed conditions in healthy Chinese volunteers. Methods Seven subjects were assigned to take a single dose of 47. 5 mg metoprolol succiniate sustained-released tablet in the fasting state. Eight subjects were administered a single dose of 47. 5 mg metoprolol succiniate sustained-released tablet after a high-fat meal. The plasma concentrations of metoprolol were assayed with liquid chromatography-tandem mass spectrometry. Pharmacokinetic parameters were calculated with Wn Nonlin ver. 6. 4. Results No drug-related adverse events and serious adverse events were observed. The pharmacokinetic parameters in the fasting state were as follows: Cmax( 14. 63 ± 8. 93) ng · m L-1, tmax( 9. 43 ± 2. 76) h,t1/2( 9. 36 ± 5. 76) h,AUC0-t( 343. 63 ± 262. 07)ng·m L-1·h,AUCinf( 359. 65 ± 259. 29) ng · m L-1· h,clearance( 188. 58 ± 109. 10) L·h-1,apparent volume of distribution( 3031. 36 ± 4029. 78) L. The pharmacokinetic parameters in the fed state were as follows: Cmax( 19. 56 ± 14. 89) ng·m L-1,tmax( 6. 00 ± 1. 07) h,t1/2( 6. 27 ± 1. 37) h,AUC0-t( 391. 07 ± 307. 06) ng·m L-1·h,AUCinf( 395. 84 ± 311. 42) ng·m L-1·h,clearance( 225. 97 ± 201. 53)L·h-1,apparent volume of distribution( 2022. 20 ± 1842. 51) L. Conclusion After a single oral dose of metoprolol succiniate administered to the healthy Chinese volunteers,tmaxin the fed state was shorter compared with that in the fasting state,no obvious difference of was observed between the exposures in the fasting and fed state.

  • 【文献出处】 中国临床药理学杂志 ,The Chinese Journal of Clinical Pharmacology , 编辑部邮箱 ,2018年23期
  • 【分类号】R969.1
  • 【被引频次】3
  • 【下载频次】287
节点文献中: 

本文链接的文献网络图示:

本文的引文网络